Procter & Gamble Health Limited (PGHL) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE199A01012
Key metrics
- Market Cap
- ₹9,474 Cr
- P/E Ratio
- 26.56
- EPS
- 214.91
- Book Value
- 316.01
- P/B Ratio
- 18.06
- ROE
- 62.32%
- ROCE
- 81.12%
- Debt / Equity
- 0.02
- Net Margin
- 23.22%
- Revenue Growth
- 24.66%
- Profit Growth
- 62.66%
- Dividend Yield
- 2.69%
- 52W High
- ₹6,975.00
- 52W Low
- ₹4,707.00
- Market Cap Band
- mid cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. The company operates as a subsidiary of Procter & Gamble Overseas India B.V.
- Headquarters
- Mumbai, India
- Employees
- 1,276
- Promoter Holding
- 52.19%
The full Procter & Gamble Health Limited analysis
Create a free account to open the complete PGHL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.